正泰生物科技股份有限公司
Company introduction
Team
Fundraising resume
Solution
Company business
Customer pain points
Product
Market size
Competing products
Business model
Start now reason
Financial condition
operating status
Recent news
Fundraising in progress
Angel
$5,000,000.00 TWD
我們擁有前沿的生物合成技術以及業界經驗,透過生物合成方式優化菌株,將其商業化、強化競爭力,並符合ESG精神,現以生醫領域為主軸發展相關商品。
9 days ago
Registration place
未提供Establishment status
2022-01-11
Capital amount
$1,200,000.00 TWD
Number of employees
1~10人
Patent
M657317長效型敷料結構
M628338生物奈米載體複合材料製造裝置